Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-11-15 00:00:00 ET · period of report 2023-11-13 · accession 0001628280-23-039096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-15 | 2023-11-13 | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $10.77 | -132 | 275.7K | -0.0% | -$1,422 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-13 | S | D | 132 | $10.77 | 275,726 | D | — | — |